for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Pfizer Inc.

PFE.N

Latest Trade

36.55USD

Change

0.07(+0.19%)

Volume

7,153,002

Today's Range

36.26

 - 

36.83

52 Week Range

27.89

 - 

43.02

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
36.48
Open
36.35
Volume
7,153,002
3M AVG Volume
949.46
Today's High
36.83
Today's Low
36.26
52 Week High
43.02
52 Week Low
27.89
Shares Out (MIL)
5,559.96
Market Cap (MIL)
203,216.60
Forward P/E
12.71
Dividend (Yield %)
4.27

Next Event

Dividend For PFE.N - 0.3900 USD

Latest Developments

More

Canada says Pfizer to slow deliveries of COVID-19 vaccines - procurement minister

EMA Says To Evaluate Safety Reports Of COVID-19 Vaccines From January

Pfizer’s Xalkori Approved By FDA For ALK-Positive Anaplastic Large Cell Lymphoma

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Pfizer Inc.

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines and vaccines. IH therapeutic areas include internal medicine, vaccines, oncology, inflammation and immunology, rare diseases and consumer healthcare. EH includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems. EH also includes a research and development (R&D) organization, as well as its contract manufacturing business. Its brands include Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq and Viagra.

Industry

Biotechnology & Drugs

Contact Info

235 E 42ND ST

NEW YORK, NY

10017-5703

United States

+1.212.5732323

https://www.pfizer.com/

Executive Leadership

Albert Bourla

Chairman of the Board, Chief Executive Officer

John D. Young

Chief Business Officer, Group President

Frank A. D'Amelio

Chief Financial Officer, Executive Vice President - Business Operations and Global Supply

Angela Hwang

Group President, Pfizer Biopharmaceuticals Group

Dawn Rogers

Chief Human Resource Officer, Executive Vice President

Key Stats

2.67 mean rating - 21 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2017

52.5K

2018

53.6K

2019

51.8K

2020(E)

48.7K
EPS (USD)

2017

2.650

2018

3.000

2019

2.950

2020(E)

2.855
Price To Earnings (TTM)
24.57
Price To Sales (TTM)
4.18
Price To Book (MRQ)
3.11
Price To Cash Flow (TTM)
15.04
Total Debt To Equity (MRQ)
96.77
LT Debt To Equity (MRQ)
76.29
Return on Investment (TTM)
6.05
Return on Equity (TTM)
4.81

Latest News

Latest News

U.S. CDC says 21.8 million doses of COVID-19 vaccines administered

The U.S. Centers for Disease Control and Prevention said it had administered 21,848,655 doses of COVID-19 vaccines in the country as of Sunday morning.

Italy to take legal action on COVID vaccine delays to get doses

Italy will take legal action and step up pressure in Brussels against Pfizer Inc and AstraZeneca over delays in deliveries of COVID-19 vaccines with a view to securing agreed supplies, Foreign Minister Luigi Di Maio said on Sunday.

Italy to take legal action over COVID vaccine delays to secure doses, says minister

Italy will take legal action against Pfizer and Astrazeneca over delays in deliveries of COVID-19 vaccines with the aim of securing the doses rather than to seek damages, Foreign Minister Luigi Di Maio said on Sunday.

EU says it will make vaccine companies respect supply contracts: Michel

The European Union will make pharmaceutical companies respect contracts they have signed for the supply of COVID-19 vaccines, European Council President Charles Michel said on Sunday.

Australia has eye on vaccination drive even though coronavirus under control

Australia recorded no new local coronavirus cases on Sunday, maintaining a recent run of success in keeping the virus at bay, but nevertheless is keen to press on with its vaccination campaign from next month, government officials said.

U.S. CDC says 41.4 million doses of COVID-19 vaccines distributed, 20.5 million administered

The U.S. Centers for Disease Control and Prevention said it had administered 20,537,990 doses of COVID-19 vaccines in the country as of Saturday morning and distributed 41,411,550 doses.

UK vaccine roll-out speeds up but doctors want quicker second dose

Britain's COVID-19 vaccination push gathered pace on Saturday, with 5.9 million people now having had a first dose, but doctors challenged the government over its policy of delaying a second shot of the Pfizer vaccine for up to 12 weeks.

Italy says delays in vaccine supplies unacceptable

Italian Prime Minister Giuseppe Conte lashed out at suppliers of COVID-19 vaccines on Saturday, saying delays in deliveries amounted to a serious breach of contractual obligations.

Italy PM says vaccine supply delays are serious contract violations

Delays in supply of vaccines to Italy from Pfizer and, possibly, AstraZeneca amount to serious violations of contractual agreements and Rome will take countermeasures, Prime Minister Giuseppe Conte said.

UK doctors call for shorter gap between Pfizer vaccine doses

A group of British doctors have written to England's chief medical officer to tell him to cut the gap between doses of the Pfizer and BioNTech vaccine to six weeks from up to 12.

Factbox: Latest on worldwide spread of the coronavirus

U.S. President Joe Biden will sign orders to speed delivery of coronavirus stimulus checks and food aid, while Europe's vaccination drive was dealt another blow when AstraZeneca said initial deliveries to the region will fall short of the targeted volumes.

39.9 million doses of COVID-19 vaccines distributed, 19.1 million administered: U.S. CDC

The U.S. Centers for Disease Control and Prevention said it had administered 19,107,959 doses of COVID-19 vaccines in the country as of Friday morning and distributed 39,892,400 doses.

Canada's Trudeau presses Pfizer CEO on vaccine shortage, hints at travel crackdown

Prime Minister Justin Trudeau said on Friday that Pfizer had reassured him it would meet Canada's vaccine order in full by end-March as, with a second COVID wave spreading across the country, he hinted at a clampdown on citizens leaving home.

WHO says Pfizer deal could allow poor countries to start vaccinating in Feb.

The World Health Organization said on Friday it had reached an agreement with Pfizer/BioNTech for 40 million doses of its COVID-19 vaccine and should be able to start delivering vaccines to poor and lower-middle income countries next month under its COVAX programme.

UPDATE 2-WHO says Pfizer deal could allow poor countries to start vaccinating in Feb

* GAVI to give countries supply breakdown soon (Adds detail, quotes throughout)

Fact check: Vaccine production was not halted due to deaths caused by COVID vaccines

A video that covers a range of conspiracies regarding COVID-19 vaccines is being shared on social media. The video includes the false suggestion that the vaccine manufacturer Pfizer shut down production because of deaths among vaccine recipients. There are other claims and...

Mexico may delay second doses of COVID-19 vaccine, allows private orders

Mexico's government said on Friday the second round of doses of the Pfizer COVID-19 vaccine could be delayed and private companies will be allowed to purchase the drugs directly as the country struggles to keep rampant infections in check.

Pfizer finishes enrolling kids in its COVID-19 vaccine study

Pfizer Inc said on Friday it had finished enrolling children aged between 12 and 15 in a study testing its COVID-19 vaccine, as the U.S. drugmaker seeks to expand the shot's use among different age groups.

French Indian Ocean territory to keep COVID-19 shots at secret location

France's Indian Ocean territory of Mayotte will store its first vials of the Pfizer/BioNTech vaccine at a secret and secure location when they arrive on Sunday to deter would-be thieves, the local health authority chief said.

Canada PM Trudeau said he talked to Pfizer CEO about COVID-19 vaccine shortage

Canadian Prime Minister Justin Trudeau said on Friday he had talked to Pfizer Inc Chief Executive Albert Bourla about shortages of the firm's COVID-19 vaccine and said the next few weeks would be challenging.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up